Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma (Q40694541)
scientific article published on November 1994
Language:
(P31) (Q13442814)
(P304) 1275-1280
(P407) (Q1860)
(P433) 14
(P478) 12
(P577) Tuesday, November 1, 1994
(P921) (Q5452194)
(P1104) 6
(P1433) (Q7907941)
(P1476) "Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma" (language: en)
(P2093) P O Livingston
S Adluri
F Helling
T J Yao
C R Kensil
M J Newman
D Marciani
(P2860) (Q93630157)
(Q72377535)
(Q54088424)
(Q70577158)
(Q45863984)
(Q49056624)
(Q68815180)
(Q35190753)
(Q35300674)
other details
description scientific article published on November 1994

External Links